N Fersis
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
Hohaus S, Wallwiener D, Martin S, Voso M, Huober J, Fersis N, Bastert G, Haas R. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer. Seminars in oncology 1998; 25:7-11; discussion 45-8.
01.04.1998Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
01.04.1998Seminars in oncology 1998; 25:7-11; discussion 45-8
Hohaus S, Wallwiener D, Martin S, Voso M T, Huober Jens, Fersis N, Bastert G, Haas R
Klinisch relevante Prognosefaktoren beim Mammakarzinom
Costa S, von Minkwitz G, Gremm B, Huober J, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel I, Kaufmann M, Bastert G. Klinisch relevante Prognosefaktoren beim Mammakarzinom. Klin Lab 1994; 40:1153-1166.
01.01.1994Klinisch relevante Prognosefaktoren beim Mammakarzinom
01.01.1994Klin Lab 1994; 40:1153-1166
Costa SD, von Minkwitz G, Gremm B, Huober Jens, Fersis N, Schmid H, Wallwiener D, Müller H, Eppenberger U, Diel IJ, Kaufmann M, Bastert G